{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:24:53Z","timestamp":1783441493647,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Research Project of Jiangsu Provincial Health Commission","award":["Z2023060"],"award-info":[{"award-number":["Z2023060"]}]},{"name":"\u201cScientific and Educational Prosperity\u201d Youth Science and Technology Project of Suzhou","award":["KJXW2022020"],"award-info":[{"award-number":["KJXW2022020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Infectious mononucleosis (IM) is a common disease in children; however, liver injury is its most common complication. However, the pathogenesis of IM complicated with liver injury is ambiguous. Thus, this study aimed to explore the potential mechanism of IM-associated liver injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study was conducted at the Children\u2019s Hospital of Soochow University by collecting peripheral blood of 70 hospitalized children with IM. These patients were categorized into the liver injury (LIG,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935) and the non-liver injury groups (NLIG,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935), respectively. Subsequently, PBMCs and plasma were separated and obtained. PBMCs transcriptome sequencing was performed in two groups (5 cases in each group), and significantly differentially expressed genes (DEGs) were screened. Additionally, GO function enrichment, KEGG enrichment and GSEA analyses were performed. RT-PCR helped to detect the relative GBP5, NLRP3 and caspase-1 expressions in two groups (30 cases in each group) while the two groups\u2019 caspase-1, IL-1\u03b2 and IL-18 in plasma levels were measured by ELISA. Thus, clinical and laboratory datas of 60 hospitalized children with IM were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptome sequencing results showed that 171 DEGs were screened in the NLIG group, compared with the LIG. Among them, 154 DEGs were up-regulated, and 17 were down-regulated, respectively. KEGG and GSEA analyses showed that IM-associated liver injury is correlated with a NOD-like receptor signaling pathway. Statistically significant differences were observed in the white blood cell and lymphocyte counts, CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells, CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, alanine aminotransferase (ALT), aspartate transaminase (AST), and lactate dehydrogenase (LDH) of the two groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Compared with NLIG, GBP5, NLRP3 and caspase-1 expressions in PBMCs, as well as the caspase-1, IL-1\u03b2 and IL-18 in plasma levels, were significantly higher in LIG (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). A correlation analysis revealed a positive correlation of GBP5 with LDH, ALT, AST, CD3\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells and NLRP3 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings demonstrate that GBP5 contributes to liver injury in IM children through the NLRP3-dependent pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-01907-x","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:04:10Z","timestamp":1741777450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical significance and pathogenesis of GBP5 in infectious mononucleosis associated liver injury"],"prefix":"10.1186","volume":"51","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7667-2873","authenticated-orcid":false,"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"1907_CR1","doi-asserted-by":"crossref","unstructured":"Cai X, Ebell MH, Haines L. Accuracy of signs, symptoms, and hematologic parameters for the diagnosis of infectious mononucleosis: a systematic review and Meta-analysis[J]. J Am Board Fam Med 2021,34(6):1141\u201356.","DOI":"10.3122\/jabfm.2021.06.210217"},{"issue":"2","key":"1907_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jped.2021.05.006","volume":"98","author":"T Shi","year":"2022","unstructured":"Shi T, Huang LL, Tian JM. Prevalence of Epstein-Barr viral DNA among children at a single hospital in Suzhou, China[J]. J Pediatr (Rio J). 2022;98(2):142\u20136.","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"1907_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13052-022-01352-0","volume":"48","author":"S Accomando","year":"2022","unstructured":"Accomando S, Restivo GA, Scalzo S, et al. Epstein-Barr virus-associated acute pancreatitis: a clinical report and review of literature[J]. Ital J Pediatr. 2022;48(1):160.","journal-title":"Ital J Pediatr"},{"key":"1907_CR4","doi-asserted-by":"crossref","unstructured":"Akkoc G, Kadayifci EK, Karaaslan A et al. Epstein-Barr virus encephalitis in an immunocompetent child: A case report and management of Epstein-Barr virus encephalitis[J]. Case Rep Infect Dis,2016,2016:7549252.","DOI":"10.1155\/2016\/7549252"},{"issue":"1","key":"1907_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12519-011-0244-1","volume":"7","author":"LW Gao","year":"2011","unstructured":"Gao LW, Xie ZD, Liu YY, et al. Epidemiologic and clinical characteristics of infectious mononucleosis associated with Epstein-Barr virus infection in children in Beijing,China[J]. World J Pediatr. 2011;7(1):45\u20139.","journal-title":"World J Pediatr"},{"issue":"6","key":"1907_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpeds.2019.01.035","volume":"209","author":"BZ Katz","year":"2019","unstructured":"Katz BZ, Reuter C, Lupovitch Y, et al. A validated scale for assessing the severity of acute infectious Mononucleosis[J]. J Pediatr. 2019;209(6):130\u20133.","journal-title":"J Pediatr"},{"key":"1907_CR7","doi-asserted-by":"crossref","unstructured":"Teijido J, Tillotson K, Liu JM. A rare presentation of Epstein-Barr virus Infection[J]. J Emerg Med 2020,58(2):e71\u20133.","DOI":"10.1016\/j.jemermed.2019.11.043"},{"key":"1907_CR8","doi-asserted-by":"crossref","unstructured":"Herold J, Grimaldo F. Epstein-Barr Virus-induced Jaundice[J]. Clin Pract Cases Emerg Med 2020,4(1):69\u201371.","DOI":"10.5811\/cpcem.2019.10.45049"},{"issue":"17","key":"1907_CR9","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1016\/j.jmb.2016.04.032","volume":"428","author":"D Pilla-Moffett","year":"2016","unstructured":"Pilla-Moffett D, Barber MF, Taylor GA, et al. Interferon-Inducible GTPases in host resistance, inflammation and Disease[J]. J Mol Biol. 2016;428(17):3495\u2013513.","journal-title":"J Mol Biol"},{"issue":"1","key":"1907_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12879-022-07214-8","volume":"22","author":"XY Yao","year":"2022","unstructured":"Yao XY, Liu W, Li XF, et al. Whole blood GBP5 protein levels in patients with and without active tuberculosis[J]. BMC Infect Dis. 2022;22(1):328.","journal-title":"BMC Infect Dis"},{"key":"1907_CR11","doi-asserted-by":"crossref","unstructured":"Li Y, Wang W, Liu Y et al. Diminished immune response and elevated abundance in gut microbe Dubosiella in mouse models of chronic colitis with GBP5 Deficiency[J]. Biomolecules,2024,14(7):873.","DOI":"10.3390\/biom14070873"},{"issue":"4","key":"1907_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/JLB.4MR0118-038R","volume":"104","author":"JC Santos","year":"2018","unstructured":"Santos JC, Broz P. Sensing of invading pathogens by GBPs: at the crossroads between cell-autonomous and innate immunity[J]. J Leukoc Biol. 2018;104(4):729\u201335.","journal-title":"J Leukoc Biol"},{"key":"1907_CR13","doi-asserted-by":"crossref","unstructured":"Feng J, Cao Z, Wang L et al. Inducible GBP5 mediates the antiviral response via interferon-related pathways during influenza a virus infection[J]. J Innate Immun 2017,9(4):419\u201335.","DOI":"10.1159\/000460294"},{"key":"1907_CR14","doi-asserted-by":"crossref","unstructured":"Virreira WS, Niedelman W, Jensen KD et al. Determinants of GBP recruitment to Toxoplasma gondii vacuoles and the parasitic factors that control it[J]. PLoS One 2011,6(9):e24434.","DOI":"10.1371\/journal.pone.0024434"},{"key":"1907_CR15","doi-asserted-by":"crossref","unstructured":"Li P, Jiang W, Yu Q et al. Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defence[J]. Nat 2017,551(7680):378\u201383.","DOI":"10.1038\/nature24467"},{"issue":"6","key":"1907_CR16","doi-asserted-by":"publisher","first-page":"e21672","DOI":"10.1096\/fj.202100234R","volume":"35","author":"HL Guo","year":"2021","unstructured":"Guo HL, Ni MM, Xu J, et al. Transcriptional enhancement of GBP-5 by BATF aggravates sepsis-associated liver injury via NLRP3 inflammasome activation[J]. FASEB J. 2021;35(6):e21672.","journal-title":"FASEB J"},{"issue":"1","key":"1907_CR17","doi-asserted-by":"publisher","first-page":"e22119","DOI":"10.1096\/fj.202101448R","volume":"36","author":"KX Ding","year":"2022","unstructured":"Ding KX, Li XZ, Ren XM, et al. GBP5 promotes liver injury and inflammation by inducing hepatocyte apoptosis[J]. FASEB J. 2022;36(1):e22119.","journal-title":"FASEB J"},{"key":"1907_CR18","unstructured":"Subspecialty Group of Infectious Diseases, the Society of Pediatrics, Chinese Medical Association National Children\u2019s Epstein-Barr Virus Infection Cooperative Group. Experts consensus on diagnosis and treatment of Epstein-Barr virus infection-related diseases in children[J]. Zhonghua Er Ke Za Zhi 2021,59(11):905\u201311."},{"key":"1907_CR19","unstructured":"Maeda A, Sato T, Wakiguchi H. Epidemiology of Epstein-Barr virus (EBV) infection and EBV-associated diseases[J]. Japanese J Clin Med 2006,64(3):609\u201312."},{"key":"1907_CR20","doi-asserted-by":"crossref","unstructured":"MELLINGER JL, ROSSARO L, NAUGLER WE et al. Epstein-Barr virus(EBV)related acute liver failure: a case series from the US acute liver failure study Group[J]. Dig Dis Sci 2014,59(7):1630\u20137.","DOI":"10.1007\/s10620-014-3029-2"},{"key":"1907_CR21","doi-asserted-by":"crossref","unstructured":"KIM BH, SHENOY AR, KUMAR P et al. A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection[J]. Sci 2011,332(6030)717\u201321.","DOI":"10.1126\/science.1201711"},{"key":"1907_CR22","doi-asserted-by":"crossref","unstructured":"Li ZL, Qu XL, Liu X et al. GBP5 is an Interferon-Induced inhibitor of respiratory syncytial Virus[J]. J Virol 2020,94(21):e01407\u201320.","DOI":"10.1128\/JVI.01407-20"},{"key":"1907_CR23","doi-asserted-by":"crossref","unstructured":"Mangan MSJ, Olhava EJ, Roush WR et al. Targeting the NLRP3 inflammasome in inflammatory diseases[J]. Nat Rev Drug Discov 2018,17(9):688.","DOI":"10.1038\/nrd.2018.149"},{"issue":"13","key":"1907_CR24","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation[J]. Int J Mol Sci. 2019;20(13):3328.","journal-title":"Int J Mol Sci"},{"key":"1907_CR25","doi-asserted-by":"crossref","unstructured":"SZABO G, PETRASEK J. Inflammasome activation and function in liver disease[J]. Nat Rev Gastro Hepat 2015,12(7):387\u2013400.","DOI":"10.1038\/nrgastro.2015.94"},{"key":"1907_CR26","doi-asserted-by":"crossref","unstructured":"Yu CQ, Chen P, Miao LY et al. The role of the NLRP3 inflammasome and programmed cell death in acute liver Injury[J]. Int J Mol Sci 2023,24(4):3067.","DOI":"10.3390\/ijms24043067"},{"key":"1907_CR27","doi-asserted-by":"crossref","unstructured":"Shenoy AR, Wellington DA, Kumar P et al. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals[J]. Sci 2012,336(6080):481\u20135.","DOI":"10.1126\/science.1217141"},{"key":"1907_CR28","doi-asserted-by":"crossref","unstructured":"Cerqueira DM, T\u00falio R, Gomes M, Silva LN. A, Guanylate-binding protein 5 licenses caspase-11 for Gasdermin-D mediated host resistance to Brucella abortus infection[J]. PLoS Pathog,2018:14(12):e1007519.","DOI":"10.1371\/journal.ppat.1007519"},{"issue":"8","key":"1907_CR29","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/bph.16002","volume":"180","author":"P Liu","year":"2023","unstructured":"Liu P, Ye LH, Ren YS, et al. Chemotherapy-induced phlebitis via the GBP5\/NLRP3 inflammasome axis and the therapeutic effect of aescin[J]. Br J Pharmacol. 2023;180(8):1132\u201347.","journal-title":"Br J Pharmacol"},{"key":"1907_CR30","doi-asserted-by":"crossref","unstructured":"Li Q, Tan Y, Chen SN et al. Irisin alleviates LPS-induced liver injury and inflammation through Inhibition of NLRP3 inflammasome and NF-\u03baB signaling[J]. J Recept Signal Transduct Res 2021,41(3):294\u2013303.","DOI":"10.1080\/10799893.2020.1808675"},{"key":"1907_CR31","doi-asserted-by":"crossref","unstructured":"Li L, Xu S, Wang WY et al. Bruceine A alleviates alcoholic liver disease by inhibiting AIM2 inflammasome activation via activating FXR[J]. Phytomedicine,2024,130:155693.","DOI":"10.1016\/j.phymed.2024.155693"},{"key":"1907_CR32","doi-asserted-by":"crossref","unstructured":"Li YC, Lin XT, Wang WX et al. The Proinflammatory role of Guanylate-Binding protein 5 in inflammatory bowel Diseases[J]. Front Microbiol,2022,13:926915.","DOI":"10.3389\/fmicb.2022.926915"},{"issue":"12","key":"1907_CR33","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1038\/s41401-023-01124-4","volume":"44","author":"JM Li","year":"2023","unstructured":"Li JM, Deng HS, Yao YD, et al. Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways[J]. Acta Pharmacol Sin. 2023;44(12):2504\u201324.","journal-title":"Acta Pharmacol Sin"},{"key":"1907_CR34","doi-asserted-by":"crossref","unstructured":"Aslan N, Watkin LB, Gil A et al. Severity of acute infectious mononucleosis correlates with cross-reactive influenza CD8\u2009+\u2009T-cell receptor repertoires[J]. mBio,2017,8(6):e01841\u201317.","DOI":"10.1128\/mBio.01841-17"},{"key":"1907_CR35","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhao Y, Jiang Y et al. Effects of Epstein-Barr virus infection on liver function in children[J]. J Infect Public Health 2020,13(2):260\u20135.","DOI":"10.1016\/j.jiph.2019.11.009"},{"issue":"2","key":"1907_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.advms.2014.04.003","volume":"59","author":"A Sulik","year":"2014","unstructured":"Sulik A, Oldak E, Kroten A, et al. Epstein-Barr virus effect on frequency of functionally distinct T cell subsets in children with infectious Mononucleosis[J]. Adv Med Sci. 2014;59(2):227\u201331.","journal-title":"Adv Med Sci"},{"key":"1907_CR37","doi-asserted-by":"crossref","unstructured":"Wang Y, Luo Y, Tang G et al. HLA-DR expression level in CD8\u2009+\u2009T cells correlates with the severity of children with acuteinfectious Mononucleosis[J]. Front Immunol,2021,12:753290.","DOI":"10.3389\/fimmu.2021.753290"},{"issue":"1","key":"1907_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1189\/jlb.4MR0516-223R","volume":"101","author":"SM Man","year":"2017","unstructured":"Man SM, Place DE, Kuriakose T, et al. Interferon-inducible guanylate-binding proteins at the interface of cell-autonomous immunity and inflammasome activation[J]. J Leukoc Biol. 2017;101(1):143\u201350.","journal-title":"J Leukoc Biol"},{"key":"1907_CR39","doi-asserted-by":"crossref","unstructured":"Krapp C, Hotter D, Gawanbacht A et al. Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity[J]. Cell Host Microbe 2016,9(4):504\u201314.","DOI":"10.1016\/j.chom.2016.02.019"},{"key":"1907_CR40","doi-asserted-by":"crossref","unstructured":"Fourcade G, Germi R, Guerber F et al. Evolution of EBV Seropre Valence and primary infection age in a French hospital and a City laboratory network,2000\u20132016[J]. PLoS One,2017,12(4):e0175574.","DOI":"10.1371\/journal.pone.0175574"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01907-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01907-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01907-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T20:58:50Z","timestamp":1741813130000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01907-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1907"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01907-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5010171\/v1","asserted-by":"object"}]},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Children\u2019s Hospital of Soochow University(Ethics approval number: 2023CS222). Written informed consent was obtained from the parents or legal guardians of all participants by the researchers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the content, and they agree to submit it for consideration for publication in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}